SHPL-49 Injection

SHPL-49 · Shanghai Hutchison Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHPL-49 Injection, covering 2025-10-28 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke [Phase 3]